Detecting early onset of anthracyclines-induced cardiotoxicity using a novel panel of biomarkers in West-Virginian population with breast cancer

Cardiotoxic manifestation associated with breast cancer treatment by anthracycline regimen increases patients’ susceptibility to myocardial injury, reduction in left ventricular ejection fraction and complications associated with heart failure. There is currently no standardized, minimally invasive,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakhani, Hari Vishal, Pillai, Sneha S., Zehra, Mishghan, Dao, Benjamin, Tirona, Maria Tria, Thompson, Ellen, Sodhi, Komal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041906/
https://www.ncbi.nlm.nih.gov/pubmed/33846495
http://dx.doi.org/10.1038/s41598-021-87209-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041906/
https://www.ncbi.nlm.nih.gov/pubmed/33846495
http://dx.doi.org/10.1038/s41598-021-87209-8

Ejemplares similares